Shanghai Medicilon Inc. (SHA:688202)
China
· Delayed Price · Currency is CNY 65.75
-1.80 (-2.66%)
At close: Apr 29, 2026
Shanghai Medicilon Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -167.83 | -330.85 | -33.21 | 338.24 | 282.22 | Upgrade
|
| Depreciation & Amortization | 108.88 | 111.31 | 103.66 | 79.22 | 58.5 | Upgrade
|
| Other Amortization | 32.72 | 53.76 | 38.62 | 25.65 | 18.04 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.95 | 1.12 | 0.34 | 0.87 | 1.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | 5.13 | 18.42 | - | 1.64 | 0.84 | Upgrade
|
| Loss (Gain) From Sale of Investments | -15.17 | -7.02 | -6.33 | -2.46 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 66.23 | 110.45 | 44.07 | 21.86 | 7.68 | Upgrade
|
| Other Operating Activities | 19.81 | 30.18 | 27.26 | -3.65 | 5.89 | Upgrade
|
| Change in Accounts Receivable | 25.13 | -17.22 | -60.36 | -434.33 | -104.96 | Upgrade
|
| Change in Inventory | -15.64 | 45.21 | -11.69 | -87.64 | -50.79 | Upgrade
|
| Change in Accounts Payable | 82.77 | 10.05 | -45.19 | 8.11 | 203.04 | Upgrade
|
| Change in Other Net Operating Assets | -21.64 | 1.96 | 2.76 | 15.59 | 19.28 | Upgrade
|
| Operating Cash Flow | 105.17 | -22.75 | 33.32 | -21.33 | 452.94 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 118.00% | Upgrade
|
| Capital Expenditures | -69.03 | -110.39 | -185.68 | -404.06 | -292.71 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.07 | 0.01 | 0.27 | - | 0.16 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -7 | Upgrade
|
| Investment in Securities | 132.77 | 23.27 | -604.65 | 90 | -100 | Upgrade
|
| Other Investing Activities | 10.75 | -2.86 | 2.52 | 2.44 | - | Upgrade
|
| Investing Cash Flow | 74.56 | -89.97 | -787.55 | -311.62 | -399.55 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 279 | - | Upgrade
|
| Long-Term Debt Issued | 360.08 | 320 | 457.1 | - | - | Upgrade
|
| Total Debt Issued | 360.08 | 320 | 457.1 | 279 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -50 | - | Upgrade
|
| Long-Term Debt Repaid | -512.48 | -379.48 | -357.74 | -20.19 | -13.9 | Upgrade
|
| Total Debt Repaid | -512.48 | -379.48 | -357.74 | -70.19 | -13.9 | Upgrade
|
| Net Debt Issued (Repaid) | -152.4 | -59.48 | 99.37 | 208.81 | -13.9 | Upgrade
|
| Issuance of Common Stock | 23.94 | - | 1,007 | 6.51 | 6.99 | Upgrade
|
| Repurchase of Common Stock | -50.09 | -40 | -19.99 | - | - | Upgrade
|
| Common Dividends Paid | -7.42 | -6.97 | -42.14 | -87.33 | -39.06 | Upgrade
|
| Other Financing Activities | - | -0.26 | -14.45 | -19.06 | -60 | Upgrade
|
| Financing Cash Flow | -185.97 | -106.71 | 1,030 | 108.94 | -105.97 | Upgrade
|
| Foreign Exchange Rate Adjustments | -2.11 | 6.13 | -0.19 | 8.17 | -0.99 | Upgrade
|
| Net Cash Flow | -8.34 | -213.3 | 275.34 | -215.84 | -53.58 | Upgrade
|
| Free Cash Flow | 36.14 | -133.14 | -152.36 | -425.39 | 160.22 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 79.93% | Upgrade
|
| Free Cash Flow Margin | 3.11% | -12.83% | -11.16% | -25.64% | 13.73% | Upgrade
|
| Free Cash Flow Per Share | 0.27 | -0.99 | -1.19 | -3.50 | 1.32 | Upgrade
|
| Cash Income Tax Paid | -9.39 | -30.13 | -55.21 | 28.71 | -8.88 | Upgrade
|
| Levered Free Cash Flow | 160.81 | -78.05 | -159.98 | -583.36 | 14.51 | Upgrade
|
| Unlevered Free Cash Flow | 166.76 | -72.83 | -153.94 | -580.3 | 15.77 | Upgrade
|
| Change in Working Capital | 53.45 | -10.12 | -141.09 | -482.72 | 78.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.